R&D Systems™ Recombinant Human LRP-1 Cluster II Fc Chimera Protein

Description

Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity

The Recombinant Human LRP-1 Cluster II Fc Chimera Protein is derived from NS0. The Recombinant Human LRP-1 Cluster II Fc Chimera Protein has been validated for the following applications: Binding Activity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Gene ID (Entrez): 4035
• Molecular Weight (g/mol): 68.1 kDa
• Name: LRP-1 Cluster II Fc Chimera
• Quantity: 50 μg
• Source: Mouse myeloma cell line,NS0-derived human LRP-1 Cluster II protein, (N-terminus) Human LRP-1C2 (Arg786-Leu1165) Accession &Num; Q07954 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Structural Form: Disulfide-linked homodimer
• Endotoxin Concentration: <0.1 EU per 1μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 90%, by SDS-PAGE under reducing conditions and visualized by silver stain.